Sergio Maluta

Learn More
PURPOSE We performed a new phase II trial enrolling patients with newly diagnosed high-grade glioma (HGG) to test the efficacy of a weekly alternating temozolomide (TMZ) schedule after surgery and concomitant chemoradiotherapy. METHODS From January 2005 to January 2007, 34 patients (21 men, 13 women; age range 30-70, mean age 53) were enrolled. There were(More)
OBJECTIVE To investigate the pattern of care and outcomes for newly diagnosed glioblastoma in Italy and compare our results with the previous Italian Patterns of Care study to determine whether significant changes occurred in clinical practice during the past 10 years. METHODS Clinical, pathological, therapeutic, and survival data regarding 1059 patients(More)
BACKGROUND Two randomized intraoperative radiation therapy trials for early-stage breast cancer were recently published. The ELIOT Trial used electrons (IOERT), and the TARGIT-A Trial Update used 50-kV X-rays (IORT). These studies were compared for similarities and differences. The results were analyzed and used to determine which patients might be suitable(More)
INTRODUCTION Two randomized intraoperative radiation therapy trials for early-stage breast cancer were recently published. The ELIOT Trial used electrons (IOERT), and the TARGIT-A Trial Update used 50-kV X-rays (IORT). These studies were compared for similarities and differences. The results were analyzed and used to determine which patients might be(More)
T he goal of the Central Nervous System Study Group of AIRO (Italian Association of Radi ation Oncology), founded in 2005, is to promote clinical research on the management of brain tumors and to develop educa-OBJECTIVE: To investigate the pattern of care and outcomes for newly diagnosed glioblas-toma in Italy and compare our results with the previous(More)
  • 1